The aetiology of hypertrophic cardiomyopathy is unknown, although genetic factors are almost certainly involved. In addition, there is increasing evidence, both clinical and experimental, of an abnormality of catecholamine metabolism. Reports of abnormal catecholamine metabolism in neurofibromatosis have led to the suggestion that there is an aetiological link between the two diseases.
Case reports CASE 1 The index case (II.2, age 42) presented with exertional chest pain and a systolic murmur (figs 1 and 2a fig 1) .
Discussion
Cross sectional echocardiography showed hypertrophic cardiomyopathy in the index case (II.2, fig 2b) and his sister (II.1, fig 3d and The developing myocardium is known to be very sensitive to catecholamines, and in normal neonates circulating concentrations are already high. Experimental work by Olsen et al has shed some light on possible interactions in the developing myocardium. The administration of TRIAC (diethamolamine salt of triiodothyronine), a triiodothyronine analogue, to pregnant rats produced widespread cellular disarray resembling that seen in hypertrophic cardiomyopathy. This reaction could be blocked by propranolol. " Perloff suggested that a possible mechanism for the development of hypertrophic cardiomyopathy is that catecholamine abnormalities lead to cellular disarray. He postulated that the inherent isometric contraction ofmalaligned cells is less effective and leads to secondary myocardial hypertrophy. ' 
